Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Suzano
SUZ
$10.5B
| $1.51M | ﹤0.01% |
150,708
+19,028
| +14% | +$192K |
|
627
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
| $1.48M | ﹤0.01% |
14,727
+11,274
| +326% | +$1.13M |
|
628
Expeditors International
EXPD
$22B
| $1.48M | ﹤0.01% |
10,345
-585
| -5% | -$88.9K |
|
629
MSCI
MSCI
$41.6B
| $1.46M | ﹤0.01% |
2,710
-29
| -1% | -$16.4K |
|
630
Ford
F
$58.5B
| $1.45M | ﹤0.01% |
125,264
+15,078
| +14% | +$199K |
|
631
Qorvo
QRVO
$7.99B
| $1.43M | ﹤0.01% |
18,439
+22
| +0.1% | +$1.78K |
|
632
Duke Energy
DUK
$97.8B
| $1.42M | ﹤0.01% |
10,875
+2,739
| +34% | +$342K |
|
633
Vanguard Dividend Appreciation ETF
VIG
$111B
| $1.42M | ﹤0.01% |
6,595
+1,617
| +32% | +$360K |
|
634
D.R. Horton
DHI
$40B
| $1.39M | ﹤0.01% |
10,137
-1,075
| -10% | -$162K |
|
635
Roper Technologies
ROP
$38.8B
| $1.39M | ﹤0.01% |
3,918
-679
| -15% | -$250K |
|
636
TD Synnex
SNX
$20.4B
| $1.38M | ﹤0.01% |
8,183
-93
| -1% | -$14.7K |
|
637
Aflac
AFL
$64.9B
| $1.38M | ﹤0.01% |
12,565
+390
| +3% | +$43.2K |
|
638
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
| $1.38M | ﹤0.01% |
19,624
+1,526
| +8% | +$113K |
|
|
EMBJ
639
Embraer S.A. ADS
EMBJ
$12.2B
| $1.37M | ﹤0.01% |
+23,014
| New | +$1.58M |
|
640
Synopsys
SNPS
$74.4B
| $1.37M | ﹤0.01% |
3,443
-198
| -5% | -$89.5K |
|
641
iShares MSCI Taiwan ETF
EWT
$9.86B
| $1.36M | ﹤0.01% |
19,121
-915
| -5% | -$64.3K |
|
642
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $1.35M | ﹤0.01% |
11,414
-2,244
| -16% | -$268K |
|
643
3M
MMM
$90.9B
| $1.34M | ﹤0.01% |
9,243
-486
| -5% | -$77.4K |
|
644
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
| $1.34M | ﹤0.01% |
29,387
+20,732
| +240% | +$973K |
|
645
BJ's Restaurants
BJRI
$1.42B
| $1.34M | ﹤0.01% |
38,118
| – | – |
|
646
Parke Bancorp
PKBK
$401M
| $1.33M | ﹤0.01% |
+46,754
| New | +$1.28M |
|
647
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
| $1.32M | ﹤0.01% |
16,838
+4,972
| +42% | +$400K |
|
648
South Plains Financial
SPFI
$845M
| $1.32M | ﹤0.01% |
+31,544
| New | +$1.3M |
|
649
Movado Group
MOV
$849M
| $1.31M | ﹤0.01% |
53,695
| – | – |
|
650
PNC Financial Services
PNC
$99.7B
| $1.3M | ﹤0.01% |
6,260
-1,500
| -19% | -$327K |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.